Benjamin E. Ueberroth, M.D.

125 posts

Benjamin E. Ueberroth, M.D. banner
Benjamin E. Ueberroth, M.D.

Benjamin E. Ueberroth, M.D.

@UeberMD

Physician | Proud alum of @barretthonors @ASU | Lover of dogs, data, and memes | All views my own

Denver, CO Katılım Temmuz 2021
143 Takip Edilen141 Takipçiler
Benjamin E. Ueberroth, M.D. retweetledi
FOX College Football
FOX College Football@CFBONFOX·
With No. 21 @ASUFootball's victory over No. 14 BYU, the Sun Devils are 9-2 for the first time since 2014! 🙌
FOX College Football tweet media
English
20
474
3.7K
116.8K
Benjamin E. Ueberroth, M.D. retweetledi
Glen O'Humeral
Glen O'Humeral@HumeralO·
When the INR is greater than the hemoglobin
Glen O'Humeral tweet media
English
11
276
2.6K
130.8K
Benjamin E. Ueberroth, M.D.
Me every time I agree to order a salmon dish with my wife but then it gets to the table.
GIF
English
0
0
1
70
Benjamin E. Ueberroth, M.D. retweetledi
Keith Siau
Keith Siau@drkeithsiau·
The pancreas when touched during ERCP 😅
English
70
437
3.4K
310.1K
Benjamin E. Ueberroth, M.D.
Embiid, Maxey, and PG… Daryl Morey you’ve outdone yourself. Let’s sign Allen Iverson as our 12th man (a la UD Haslem with The Heat) and the trophy is ours. @sixers
Benjamin E. Ueberroth, M.D. tweet media
English
2
0
0
145
Benjamin E. Ueberroth, M.D.
Fascinating supportive tech. Can’t forget the psychosocial impacts of cancer & treatment! 👉ASC can greatly benefit some breast cancer pts 🔑Imperative to discuss benefits, AEs, costs beforehand 🤔How to improve RN support? @scalpcooling @DigniCap rdcu.be/dJ8LI
Benjamin E. Ueberroth, M.D. tweet media
English
0
0
2
88
Benjamin E. Ueberroth, M.D.
@marklewismd Definitely need to see a pre-LT response to CTX and no lesion larger than 5.5cm! Basically the Oslo Score 🇳🇴 The CEA reduction by 50% is novel from the Oslo group (Dueland et al.) Most recur to lung, wonder if lung metastasectomy post-LT can provide even more OS? Awesome!
English
0
0
1
51
Mark Lewis, MD, FASCO
Mark Lewis, MD, FASCO@marklewismd·
Liver transplant in mCRC?! TRANSMET suggests that the survival benefit -- 5-year OS rate was 73% v. 9% for chemo alone [HR 0.16; 95%CI 0.07-0.33] -- hinges on VERY careful patient selection (and does not obviate the need for post-transplant systemic control) #ASCO24 #crcsm
Mark Lewis, MD, FASCO tweet mediaMark Lewis, MD, FASCO tweet media
English
2
22
88
11K
Benjamin E. Ueberroth, M.D.
Survival numbers are incredible. Oslo 🇳🇴 group has been working on this for nearly a decade with similar (amazing) results. Barrier in US is organ availability, but ECD organs and new perfusion techniques should address this. The time is now!
Arndt Vogel@ArndtVogel

CTx & liver transplantatison vs CTx in pts with unresectable CRC liver metastases at #ASCO24 🔎prospective trial TRANSMET, 94 pts 👉40% excluded, 9 drop out, 81% underwent LTx 👉mPFS 17.4 vs 6.4, 72% recurrence after LTx 👉5yr OS: 57% vs 13% 🧐potential cure for some pts, selection is key @myESMO @ILCAnews @EASLnews #livertwitter

English
0
0
1
117